The Current Landscape and Lessons from Fecal Microbiota Transplantation for Inflammatory Bowel Disease: Past, Present, and Future

Jessica Allegretti, Lindsay M. Eysenbach, Najwa El-Nachef, Monika Fischer, Colleen Kelly, Zain Kassam

Research output: Contribution to journalReview article

16 Citations (Scopus)

Abstract

Fecal microbiota transplantation (FMT) has changed the standard of care for Clostridium difficile infection. However, there is limited data focusing on efficacy and safety profile of FMT in patients with C. difficile infection with underlying inflammatory bowel disease (IBD), including the risk of IBD flare. Recently, there is also emerging evidence supporting the role of FMT to treat IBD including promising randomized trials in ulcerative colitis. However, with heterogeneity across these studies, the clinical application of this emerging therapy has yet to be fully elucidated. Here, we aim to review the current landscape of this rapidly developing field, mapping the efficacy and safety of FMT (1) to treat C. difficile infection in patients with IBD, (2) to treat underlying IBD, and (3) outline ongoing clinical trials and the future of the microbiome space.

Original languageEnglish (US)
Pages (from-to)1710-1717
Number of pages8
JournalInflammatory Bowel Diseases
Volume23
Issue number10
DOIs
StatePublished - Oct 1 2017

Fingerprint

Clostridium Infections
Inflammatory Bowel Diseases
Clostridium difficile
Safety
Microbiota
Standard of Care
Ulcerative Colitis
Clinical Trials
Fecal Microbiota Transplantation
Therapeutics

Keywords

  • Crohn's disease
  • fecal microbiota transplantation
  • inflammatory bowel disease
  • microbiome
  • ulcerative colitis

ASJC Scopus subject areas

  • Immunology and Allergy
  • Gastroenterology

Cite this

The Current Landscape and Lessons from Fecal Microbiota Transplantation for Inflammatory Bowel Disease : Past, Present, and Future. / Allegretti, Jessica; Eysenbach, Lindsay M.; El-Nachef, Najwa; Fischer, Monika; Kelly, Colleen; Kassam, Zain.

In: Inflammatory Bowel Diseases, Vol. 23, No. 10, 01.10.2017, p. 1710-1717.

Research output: Contribution to journalReview article

Allegretti, Jessica ; Eysenbach, Lindsay M. ; El-Nachef, Najwa ; Fischer, Monika ; Kelly, Colleen ; Kassam, Zain. / The Current Landscape and Lessons from Fecal Microbiota Transplantation for Inflammatory Bowel Disease : Past, Present, and Future. In: Inflammatory Bowel Diseases. 2017 ; Vol. 23, No. 10. pp. 1710-1717.
@article{0169fb2aafa24a5a927bda814471fd5d,
title = "The Current Landscape and Lessons from Fecal Microbiota Transplantation for Inflammatory Bowel Disease: Past, Present, and Future",
abstract = "Fecal microbiota transplantation (FMT) has changed the standard of care for Clostridium difficile infection. However, there is limited data focusing on efficacy and safety profile of FMT in patients with C. difficile infection with underlying inflammatory bowel disease (IBD), including the risk of IBD flare. Recently, there is also emerging evidence supporting the role of FMT to treat IBD including promising randomized trials in ulcerative colitis. However, with heterogeneity across these studies, the clinical application of this emerging therapy has yet to be fully elucidated. Here, we aim to review the current landscape of this rapidly developing field, mapping the efficacy and safety of FMT (1) to treat C. difficile infection in patients with IBD, (2) to treat underlying IBD, and (3) outline ongoing clinical trials and the future of the microbiome space.",
keywords = "Crohn's disease, fecal microbiota transplantation, inflammatory bowel disease, microbiome, ulcerative colitis",
author = "Jessica Allegretti and Eysenbach, {Lindsay M.} and Najwa El-Nachef and Monika Fischer and Colleen Kelly and Zain Kassam",
year = "2017",
month = "10",
day = "1",
doi = "10.1097/MIB.0000000000001247",
language = "English (US)",
volume = "23",
pages = "1710--1717",
journal = "Inflammatory Bowel Diseases",
issn = "1078-0998",
publisher = "John Wiley and Sons Inc.",
number = "10",

}

TY - JOUR

T1 - The Current Landscape and Lessons from Fecal Microbiota Transplantation for Inflammatory Bowel Disease

T2 - Past, Present, and Future

AU - Allegretti, Jessica

AU - Eysenbach, Lindsay M.

AU - El-Nachef, Najwa

AU - Fischer, Monika

AU - Kelly, Colleen

AU - Kassam, Zain

PY - 2017/10/1

Y1 - 2017/10/1

N2 - Fecal microbiota transplantation (FMT) has changed the standard of care for Clostridium difficile infection. However, there is limited data focusing on efficacy and safety profile of FMT in patients with C. difficile infection with underlying inflammatory bowel disease (IBD), including the risk of IBD flare. Recently, there is also emerging evidence supporting the role of FMT to treat IBD including promising randomized trials in ulcerative colitis. However, with heterogeneity across these studies, the clinical application of this emerging therapy has yet to be fully elucidated. Here, we aim to review the current landscape of this rapidly developing field, mapping the efficacy and safety of FMT (1) to treat C. difficile infection in patients with IBD, (2) to treat underlying IBD, and (3) outline ongoing clinical trials and the future of the microbiome space.

AB - Fecal microbiota transplantation (FMT) has changed the standard of care for Clostridium difficile infection. However, there is limited data focusing on efficacy and safety profile of FMT in patients with C. difficile infection with underlying inflammatory bowel disease (IBD), including the risk of IBD flare. Recently, there is also emerging evidence supporting the role of FMT to treat IBD including promising randomized trials in ulcerative colitis. However, with heterogeneity across these studies, the clinical application of this emerging therapy has yet to be fully elucidated. Here, we aim to review the current landscape of this rapidly developing field, mapping the efficacy and safety of FMT (1) to treat C. difficile infection in patients with IBD, (2) to treat underlying IBD, and (3) outline ongoing clinical trials and the future of the microbiome space.

KW - Crohn's disease

KW - fecal microbiota transplantation

KW - inflammatory bowel disease

KW - microbiome

KW - ulcerative colitis

UR - http://www.scopus.com/inward/record.url?scp=85029748331&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85029748331&partnerID=8YFLogxK

U2 - 10.1097/MIB.0000000000001247

DO - 10.1097/MIB.0000000000001247

M3 - Review article

C2 - 28858073

AN - SCOPUS:85029748331

VL - 23

SP - 1710

EP - 1717

JO - Inflammatory Bowel Diseases

JF - Inflammatory Bowel Diseases

SN - 1078-0998

IS - 10

ER -